MEPTID®

WHO Stage II opioid
Active substance - meptazinol hydrochloride
Indication - MEPTID® is indicated in moderate to severe pain of various causes.
Composition - 1 ml of the solution for injection (1 ampoule) contains 115.6 mg meptazinol hydrochloride corresponding to 100 mg meptazinol.
Posology - The dosage is determined by the physician. The usual dose is: Adult– i.v.: 50 mg to 100 mg meptazinol (= 0.5 ml to 1 ml MEPTID®) follow-up injection of the same dose every 2 to 4 hours if necessary.– i.m.: 75 to 100 mg meptazinol (= 0.75 ml to 1 ml MEPTID®) follow-up injection of the same dose every 2 to 4 hours if necessary. For pain relief in the first stage of birth 100 mg to 150 mg meptazinol (= 1 ml to 1.5 ml MEPTID®), up to 2 mg meptazinol per kg body weight, depending on the patient's weight. Children: There is no experience with children.

Compare Add to favorites Added to favorites

Compare Add to favorites Added to favorites

Product selenase® T pro injectione (1000 µg)

• selenium pharmaceutical • Active substance - Sodium selenite pentahydrate - 50 μg selenium per ml • 1 injection vial with 20 ml solution for injection contains 1000 μg selenium. • Indications - Proven selenium deficiency that cannot be corrected via diet. Selenium deficiency may occur in maldige...

Compare
Product IMMUCOTHEL®

Active substance - Standardised immunocyanin
Indications - Relapse prevention of superficial carcinoma of the bladder [Tis, Ta–T1(G1–G3)] after transurethral resection. IMMUCOTHEL® constitutes only second line treatment in immunological treatment for relapse prevention.
• Patients appreciate the...

Compare

CPHI Online is the largest global marketplace in the pharma ingredients industry